Jim Cramer
Slowdown in tourists coming to the U.S. puts Disney’s theme park magic at risk
A slump in air travel to the U.S. is emerging in the wake of President Donald Trump’s tariffs, and it ...
Abbott Labs shares surge on earnings and a big sign of confidence in the business
Shares of Abbott Laboratories jumped Wednesday after the diversified health-care company delivered strong first-quarter results and left its earnings guidance ...
10 beaten-up stocks that are candidates for a rebound — but all are not created equal
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time ...
Nvidia, tariffs make for a confusing market. Here’s my advice for investors
“My pathway led by confusion boats / mutiny from stern to bow.” That phrase, from Bob Dylan’s 1964 classic, “My ...
We’re trimming our stake in a beaten-up stock that has taken off in 2025
We are selling 150 shares of Nextracker at roughly $41.65. Following the trade, Jim Cramer’s Charitable Trust will own 1,000 ...
nonfarm payrolls, PMI and earnings from Albertsons
CNBC’s Jim Cramer on Friday walked investors through next week’s market action, highlighting new economic data from the nonfarm payroll ...
Eli Lilly looks to extend winning streak over broad market to 6 years
Eli Lilly has outperformed the S & P 500 for five straight years as Wall Street woke up to its ...
Danaher had a disappointing 2024. Its path to success next year goes through Wall Street
Life sciences firm Danaher has certainly not been an easy stock to own this year. A wave of startups going ...
We’re buying more shares of a company that makes a key part of AI data centers
We’re buying 40 shares of Dover at roughly $200 each. Following Tuesday’s trade, Jim Cramer’s Charitable Trust will own 540 ...
Here are 4 things we’re watching in the stock market in the week ahead
Technology stocks stood tall in the first week of December trading, helping the S & P 500 and Nasdaq Composite ...
